SHL MEDICAL AND STEVANATO GROUP BRING A LONG TRACK RECORD OF JOINTLY DEVELOPING COMMERCIALLY AVAILABLE DRUG DELIVERY SYSTEMS, WITH NINE PRODUCTS SUCCESSFULLY COMMERCIALISED IN A STEVANATO GROUP SYRINGE WITH THE MOLLY AUTOINJECTOR TO DATE. SHL Medical and Stevanato Group bring a long track record of jointly developing commercially available drug delivery systems, with nine products successfully commercialised in a Stevanato Group syringe with the Molly autoinjector to date
Other contraindications and precautions for GLP-1 agonists include a history of severe allergic reactions to the medication or its components, acute or chronic pancreatitis, gallbladder disease or gallstones, and certain forms of diabetic retinopathy
These sizes are referred to as [half inch] RNS and [five eighths inch] RNS
Healthcare professionals should assess injection sites during routine appointments, providing feedback on technique and rotation adequacy
Short term effects of semaglutide on emotional eating and other abnormal eating patterns among subjects living with obesity
Pharmaceuticals 17 , 147 (2024)